Quarterly Consolidated Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7329099

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,280,000,000 JPY
3,169,000,000 JPY
Interest and dividends received
96,000,000 JPY
89,000,000 JPY
Interest paid
-170,000,000 JPY
-166,000,000 JPY
Income taxes paid
-578,000,000 JPY
-239,000,000 JPY
Net cash provided by (used in) operating activities
627,000,000 JPY
2,853,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,245,000,000 JPY
-1,546,000,000 JPY
Proceeds from sale of investment securities
84,000,000 JPY
242,000,000 JPY
Other, net
-32,000,000 JPY
-40,000,000 JPY
Net cash provided by (used in) investing activities
-3,536,000,000 JPY
-1,373,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
4,900,000,000 JPY
3,536,000,000 JPY
Repayments of long-term borrowings
-3,587,000,000 JPY
-3,819,000,000 JPY
Purchase of treasury shares
-652,000,000 JPY
-3,000,000 JPY
Dividends paid
-645,000,000 JPY
-525,000,000 JPY
Other, net
0 JPY
0 JPY
Net cash provided by (used in) financing activities
14,000,000 JPY
-813,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-2,894,000,000 JPY
667,000,000 JPY
Cash and cash equivalents
5,120,000,000 JPY
8,014,000,000 JPY
7,347,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.